Fortress Biotech Q4 EPS $(0.53) Beats $(1.97) Estimate, Sales $19.95M Beat $14.89M Estimate
Fortress Biotech Q4 EPS $(0.53) Beats $(1.97) Estimate, Sales $19.95M Beat $14.89M Estimate
Fortress Biotech第四季度每股收益美元（0.53美元）超过预期（1.97美元），销售额1,995万美元超过预期的1489万美元
Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(1.97) by 73.1 percent. This is a 55.83 percent increase over losses of $(1.20) per share from the same period last year. The company reported quarterly sales of $19.95 million which beat the analyst consensus estimate of $14.89 million by 33.96 percent. This is a 21.59 percent increase over sales of $16.40 million the same period last year.
丰泽生物科技（纳斯达克股票代码：FBIO）公布的季度亏损为每股0.53美元，比分析师普遍预期的1.97美元（1.97美元）高出73.1％。与去年同期每股亏损1.20美元（1.20）相比，增长了55.83％。该公司公布的季度销售额为1,995万美元，比分析师普遍预期的1489万美元高出33.96％。这比去年同期的1,640万美元销售额增长了21.59％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。